Evidence map›Paper›PMID 12122108›Full record

ArticleThe Journal of clinical investigation2002

Viral induction of a chronic asthma phenotype and genetic segregation from the acute response.

Michael J Walter, Jeffrey D Morton, Naohiro Kajiwara, Eugene Agapov, Michael J Holtzman

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05546645 (Validation of a Questionnaire to Assess Bronchial Mucus Hypersecretion in Asthmatic Patients. Questionnaire "T-sec"), which is not on this map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05546645 unknown statusnot on this mapstarted 2023, after this paper: background citation

Validation of a Questionnaire to Assess Bronchial Mucus Hypersecretion in Asthmatic Patients. Questionnaire "T-sec" (Secretion Test).

TypeobservationalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2023 to 2024Enrolled100ConditionsAsthmaArmsQuestionnaire
3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 174 citations in OpenAlex.

  1. Tolerogenic lung allograft microenvironment suppresses pathogenic tissue remodeling following respiratory virus infection in mice.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. bioRxiv : the preprint server for biology · 2024
    Article
  8. Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease.European respiratory review : an official journal of the European Respiratory Society · 2024
    Article
  9. An alternative mechanism for skeletal muscle dysfunction in long-term post-viral lung disease.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  10. Article
  11. Article
  12. Intermediary Role of Lung Alveolar Type 1 Cells in Epithelial Repair upon Sendai Virus Infection.American journal of respiratory cell and molecular biology · 2022
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Hypersensitivity may be involved in severe COVID-19.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Article
  18. Article
  19. Nuclear IL-33 as a growth and survival agent within basal cells.The Journal of clinical investigation · 2021
    Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael J WalterPulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Jeffrey D Morton
Naohiro Kajiwara
Eugene Agapov
Michael J Holtzman
Pulmonary and Critical Care Associates · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paramyxoviral infections cause most of the acute lower respiratory tract illness in infants and young children and predispose to the development of chronic wheezing, but the relationship between these short- and long-term viral effects are uncertain. Here we show that a single paramyxoviral infection of mice (C57BL6/J strain) not only produces acute bronchiolitis, but also triggers a chronic response with airway hyperreactivity and goblet cell hyperplasia lasting at least a year after complete viral clearance. During the acute response to virus, same-strain ICAM-1-null mice are protected from airway inflammation and hyperreactivity despite similar viral infection rates, but the chronic response proceeds despite ICAM-1 deficiency. Neither response is influenced by IFN-gamma deficiency, but the chronic response is at least partially prevented by glucocorticoid treatment. In contrast to viral infection, allergen challenge caused only short-term expression of asthma phenotypes. Thus, paramyxoviruses cause both acute airway inflammation/hyperreactivity and chronic airway remodeling/hyperreactivity phenotypes (the latter by a hit-and-run strategy, since viral effects persist after clearance). These two phenotypes can be segregated by their dependence on the ICAM-1 gene and so depend on distinct controls that appear critical for the development of lifelong airway diseases such as asthma.

Indexed as

Acute DiseaseAllergensAnimalsAsthmaBronchiolitisChild, PreschoolChronic DiseaseDexamethasoneDisease Models, AnimalGlucocorticoidsHumansInfantIntercellular Adhesion Molecule-1MiceMice, Inbred C57BLMice, KnockoutAllergensDexamethasoneGlucocorticoidsIntercellular Adhesion Molecule-1

Identifiers

PMID12122108
PMCPMC151043
OpenAlexW2159473787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.